Phase
Condition
Multiple Sclerosis
Ovarian Cancer
Cervical Cancer
Treatment
Biological Sample Collection
Clinical Study ID
Ages > 30 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age 30 days or older.
Diagnosis and/or medical history of a condition, disease, genetic background, ortrait of interest or healthy control.
Adults with decisional capacity must provide written informed consent unlessphysical limitations preclude signing.
Adults without decisional capacity to consent must a have diagnosis of AmyotrophicLateral Sclerosis (ALS), Alzheimer's Disease and Related Dementias (AD/ADRD); BattenDisease, Corticobasal Degeneration (CBD), Dementia, Frontotemporal Dementia (FTD),Huntington Disease, Lewy Body Disease, Multiple Sclerosis, Multiple System Atrophy,Parkinson's Disease (PD), Parkinsonism, and/or Progressive Supranuclear Palsy, andmust provide assent; a legally authorized representative (LAR) must also providewritten informed consent.
Minors undergoing skin collection for research purposes must have a condition,disease, genetic background, or trait of interest and parental/guardian consent.
Minors undergoing blood, and/or saliva collection for research purposes may have acondition, disease, genetic background, or trait of interest or serve as a healthycontrol and must have an available parent/guardian to provide consent.
Minors transferring biological samples and associated data from a procedure outsideof the research may have a condition, disease, genetic background, or trait ofinterest or serve as a healthy control and must have an available parent/guardian toprovide consent.
Exclusion
Exclusion Criteria:
Wards of the state.
For prospective skin samples: history of keloid formation, coagulation disorder, orallergy to the anesthetic.
For prospective blood samples: history of coagulation disorder.
For all prospective sample collections: 1) Subjects who refuse to adhere to NYSCF'sand/or a collection site's safety protocol(s) will be excluded; 2) Subjects with anAIDS diagnosis and CD4 count of less than 200 cells per microliter (mcL) of bloodwill be excluded due to increased risk of infection.
Study Design
Study Description
Connect with a study center
New York Stem Cell Foundation Research Institute
New York, New York 10019
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.